Award Notice for the instruments and reagents to perform automated microbial identification and susceptibility testing for the Brooke Army Medical Center (BAMC), Department of Pathology and Area Laboratory Services

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on August 11, 2026.

Award Information

This solicitation resulted in an award to for approximately $1,749,763 on August 11, 2026. Similar contracts are typically issued by DEPT OF DEFENSE under 325413 (In-Vitro Diagnostic Substance Manufacturing).

Award Number
W81K00-26-P-A114
Award Amount
$1,749,763
Award Date
August 11, 2026

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Set-aside for No Set Aside businesses
  • Work to be performed in JBSA FT SAM HOUSTON, TX
  • Industry: In-Vitro Diagnostic Substance Manufacturing

Contract Details

Notice ID
W81K00-26-P-A114
Opportunity Type
Award Notice
Sub-Agency
DEPT OF THE ARMY
Office
W40M MRC0 WEST
Posted Date
Wednesday, August 12, 2026
Response Deadline
Not specified
PSC Code
6640
Set-Aside
No Set Aside
Status
Active

Description

Award Notice for Purchase Order W81K00-26-P-A114 for instruments and reagents to perform automated microbial identification and susceptibility testing for the Brooke Army Medical Center (BAMC), Department of Pathology and Area Laboratory Services. Period of Performance: Base Year 10/01/2026 - 9/30/2027. Option Years - 10/01/2027 - 9/30/2031.

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in JBSA FT SAM HOUSTON, TX. This set-aside designation means eligible businesses face reduced competition from larger firms.